(2015) Anti-PD-1 and anti-PDL-1 monoclonal antibodies causing type 1 diabetes
Retatrutide is now attracting attention because it is being studied as a triple-receptor medication that activates GLP-1, GIP, and glucagon pathways
P., Mogk, S., Duszenko, M., Betzel, C., Schneider, T
Calendar 5
Patients should consult their healthcare provider or endocrinologist before making medication changes.
Probiotics and Plant-Derived Products Probiotics are not considered as pharmacological treatments, but due to their good accessibility, their popularity among patients, and applicability in IBS-D patients with contraindications, we included probiotics in this review